img

Global Lacosamide Oral Solution Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lacosamide Oral Solution Market Insights, Forecast to 2034

Lacosamide oral solution is indicated in patients 17 years and older with partial-onset seizures as adjunctive therapy. Lacosamide oral solution may be taken with or without food.
Global Lacosamide Oral Solution market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Lacosamide Oral Solution industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Lacosamide Oral Solution key manufacturers include Jiangxi Kerui Pharmaceutical Co., Ltd., China Resources Double-crane Pharmaceutical Co., Ltd., Haida Shehuage Pharmaceutical Co., Ltd., Shanghai Aucta Pharmaceuticals Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Shandong Loncom Pharmaceutical Co., Ltd, Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited and Glenmark Pharma INC, etc. Jiangxi Kerui Pharmaceutical Co., Ltd., China Resources Double-crane Pharmaceutical Co., Ltd., Haida Shehuage Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Lacosamide Oral Solution were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Lacosamide Oral Solution market and estimated to attract more attentions from industry insiders and investors.
Lacosamide Oral Solution can be divided into Generic Drug and Original Drug, etc. Generic Drug is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Lacosamide Oral Solution is widely used in various fields, such as Hospital, Retail Drug Store, Online Sales and Others, etc. Hospital provides greatest supports to the Lacosamide Oral Solution industry development. In 2022, global % sales of Lacosamide Oral Solution went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Lacosamide Oral Solution market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Lacosamide Oral Solution market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Jiangxi Kerui Pharmaceutical Co., Ltd.
China Resources Double-crane Pharmaceutical Co., Ltd.
Haida Shehuage Pharmaceutical Co., Ltd.
Shanghai Aucta Pharmaceuticals Co., Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
Shandong Loncom Pharmaceutical Co., Ltd
Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
UCB Pharma Limited
Glenmark Pharma INC
Vista Pharm INC
Segment by Type
Generic Drug
Original Drug

Segment by Application


Hospital
Retail Drug Store
Online Sales
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Lacosamide Oral Solution plant distribution, commercial date of Lacosamide Oral Solution, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Lacosamide Oral Solution introduction, etc. Lacosamide Oral Solution Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Lacosamide Oral Solution
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Lacosamide Oral Solution Product Introduction
1.2 Market by Type
1.2.1 Global Lacosamide Oral Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Market by Application
1.3.1 Global Lacosamide Oral Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Drug Store
1.3.4 Online Sales
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lacosamide Oral Solution Sales Estimates and Forecasts 2018-2029
2.2 Global Lacosamide Oral Solution Revenue by Region
2.2.1 Global Lacosamide Oral Solution Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Lacosamide Oral Solution Revenue by Region (2018-2024)
2.2.3 Global Lacosamide Oral Solution Revenue by Region (2024-2029)
2.2.4 Global Lacosamide Oral Solution Revenue Market Share by Region (2018-2029)
2.3 Global Lacosamide Oral Solution Sales Estimates and Forecasts 2018-2029
2.4 Global Lacosamide Oral Solution Sales by Region
2.4.1 Global Lacosamide Oral Solution Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Lacosamide Oral Solution Sales by Region (2018-2024)
2.4.3 Global Lacosamide Oral Solution Sales by Region (2024-2029)
2.4.4 Global Lacosamide Oral Solution Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Lacosamide Oral Solution Sales by Manufacturers
3.1.1 Global Lacosamide Oral Solution Sales by Manufacturers (2018-2024)
3.1.2 Global Lacosamide Oral Solution Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lacosamide Oral Solution in 2022
3.2 Global Lacosamide Oral Solution Revenue by Manufacturers
3.2.1 Global Lacosamide Oral Solution Revenue by Manufacturers (2018-2024)
3.2.2 Global Lacosamide Oral Solution Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Lacosamide Oral Solution Revenue in 2022
3.3 Global Key Players of Lacosamide Oral Solution, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Lacosamide Oral Solution Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lacosamide Oral Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lacosamide Oral Solution, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lacosamide Oral Solution, Product Offered and Application
3.8 Global Key Manufacturers of Lacosamide Oral Solution, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lacosamide Oral Solution Sales by Type
4.1.1 Global Lacosamide Oral Solution Historical Sales by Type (2018-2024)
4.1.2 Global Lacosamide Oral Solution Forecasted Sales by Type (2024-2029)
4.1.3 Global Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
4.2 Global Lacosamide Oral Solution Revenue by Type
4.2.1 Global Lacosamide Oral Solution Historical Revenue by Type (2018-2024)
4.2.2 Global Lacosamide Oral Solution Forecasted Revenue by Type (2024-2029)
4.2.3 Global Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
4.3 Global Lacosamide Oral Solution Price by Type
4.3.1 Global Lacosamide Oral Solution Price by Type (2018-2024)
4.3.2 Global Lacosamide Oral Solution Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Lacosamide Oral Solution Sales by Application
5.1.1 Global Lacosamide Oral Solution Historical Sales by Application (2018-2024)
5.1.2 Global Lacosamide Oral Solution Forecasted Sales by Application (2024-2029)
5.1.3 Global Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
5.2 Global Lacosamide Oral Solution Revenue by Application
5.2.1 Global Lacosamide Oral Solution Historical Revenue by Application (2018-2024)
5.2.2 Global Lacosamide Oral Solution Forecasted Revenue by Application (2024-2029)
5.2.3 Global Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
5.3 Global Lacosamide Oral Solution Price by Application
5.3.1 Global Lacosamide Oral Solution Price by Application (2018-2024)
5.3.2 Global Lacosamide Oral Solution Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Lacosamide Oral Solution Market Size by Type
6.1.1 US & Canada Lacosamide Oral Solution Sales by Type (2018-2029)
6.1.2 US & Canada Lacosamide Oral Solution Revenue by Type (2018-2029)
6.2 US & Canada Lacosamide Oral Solution Market Size by Application
6.2.1 US & Canada Lacosamide Oral Solution Sales by Application (2018-2029)
6.2.2 US & Canada Lacosamide Oral Solution Revenue by Application (2018-2029)
6.3 US & Canada Lacosamide Oral Solution Market Size by Country
6.3.1 US & Canada Lacosamide Oral Solution Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Lacosamide Oral Solution Sales by Country (2018-2029)
6.3.3 US & Canada Lacosamide Oral Solution Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Lacosamide Oral Solution Market Size by Type
7.1.1 Europe Lacosamide Oral Solution Sales by Type (2018-2029)
7.1.2 Europe Lacosamide Oral Solution Revenue by Type (2018-2029)
7.2 Europe Lacosamide Oral Solution Market Size by Application
7.2.1 Europe Lacosamide Oral Solution Sales by Application (2018-2029)
7.2.2 Europe Lacosamide Oral Solution Revenue by Application (2018-2029)
7.3 Europe Lacosamide Oral Solution Market Size by Country
7.3.1 Europe Lacosamide Oral Solution Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Lacosamide Oral Solution Sales by Country (2018-2029)
7.3.3 Europe Lacosamide Oral Solution Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Lacosamide Oral Solution Market Size
8.1.1 China Lacosamide Oral Solution Sales (2018-2029)
8.1.2 China Lacosamide Oral Solution Revenue (2018-2029)
8.2 China Lacosamide Oral Solution Market Size by Application
8.2.1 China Lacosamide Oral Solution Sales by Application (2018-2029)
8.2.2 China Lacosamide Oral Solution Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Lacosamide Oral Solution Market Size by Type
9.1.1 Asia Lacosamide Oral Solution Sales by Type (2018-2029)
9.1.2 Asia Lacosamide Oral Solution Revenue by Type (2018-2029)
9.2 Asia Lacosamide Oral Solution Market Size by Application
9.2.1 Asia Lacosamide Oral Solution Sales by Application (2018-2029)
9.2.2 Asia Lacosamide Oral Solution Revenue by Application (2018-2029)
9.3 Asia Lacosamide Oral Solution Sales by Region
9.3.1 Asia Lacosamide Oral Solution Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Lacosamide Oral Solution Revenue by Region (2018-2029)
9.3.3 Asia Lacosamide Oral Solution Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Lacosamide Oral Solution Market Size by Type
10.1.1 Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Lacosamide Oral Solution Market Size by Application
10.2.1 Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Country
10.3.1 Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Jiangxi Kerui Pharmaceutical Co., Ltd.
11.1.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
11.1.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Overview
11.1.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments
11.2 China Resources Double-crane Pharmaceutical Co., Ltd.
11.2.1 China Resources Double-crane Pharmaceutical Co., Ltd. Company Information
11.2.2 China Resources Double-crane Pharmaceutical Co., Ltd. Overview
11.2.3 China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 China Resources Double-crane Pharmaceutical Co., Ltd. Recent Developments
11.3 Haida Shehuage Pharmaceutical Co., Ltd.
11.3.1 Haida Shehuage Pharmaceutical Co., Ltd. Company Information
11.3.2 Haida Shehuage Pharmaceutical Co., Ltd. Overview
11.3.3 Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Haida Shehuage Pharmaceutical Co., Ltd. Recent Developments
11.4 Shanghai Aucta Pharmaceuticals Co., Ltd.
11.4.1 Shanghai Aucta Pharmaceuticals Co., Ltd. Company Information
11.4.2 Shanghai Aucta Pharmaceuticals Co., Ltd. Overview
11.4.3 Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shanghai Aucta Pharmaceuticals Co., Ltd. Recent Developments
11.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
11.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
11.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Overview
11.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments
11.6 Shandong Loncom Pharmaceutical Co., Ltd
11.6.1 Shandong Loncom Pharmaceutical Co., Ltd Company Information
11.6.2 Shandong Loncom Pharmaceutical Co., Ltd Overview
11.6.3 Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments
11.7 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
11.7.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
11.7.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Overview
11.7.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments
11.8 UCB Pharma Limited
11.8.1 UCB Pharma Limited Company Information
11.8.2 UCB Pharma Limited Overview
11.8.3 UCB Pharma Limited Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 UCB Pharma Limited Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 UCB Pharma Limited Recent Developments
11.9 Glenmark Pharma INC
11.9.1 Glenmark Pharma INC Company Information
11.9.2 Glenmark Pharma INC Overview
11.9.3 Glenmark Pharma INC Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Glenmark Pharma INC Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Glenmark Pharma INC Recent Developments
11.10 Vista Pharm INC
11.10.1 Vista Pharm INC Company Information
11.10.2 Vista Pharm INC Overview
11.10.3 Vista Pharm INC Lacosamide Oral Solution Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Vista Pharm INC Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vista Pharm INC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lacosamide Oral Solution Industry Chain Analysis
12.2 Lacosamide Oral Solution Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lacosamide Oral Solution Production Mode & Process
12.4 Lacosamide Oral Solution Sales and Marketing
12.4.1 Lacosamide Oral Solution Sales Channels
12.4.2 Lacosamide Oral Solution Distributors
12.5 Lacosamide Oral Solution Customers
13 Market Dynamics
13.1 Lacosamide Oral Solution Industry Trends
13.2 Lacosamide Oral Solution Market Drivers
13.3 Lacosamide Oral Solution Market Challenges
13.4 Lacosamide Oral Solution Market Restraints
14 Key Findings in The Global Lacosamide Oral Solution Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Lacosamide Oral Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Generic Drug
Table 3. Major Manufacturers of Original Drug
Table 4. Global Lacosamide Oral Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Lacosamide Oral Solution Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Lacosamide Oral Solution Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Lacosamide Oral Solution Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Lacosamide Oral Solution Revenue Market Share by Region (2018-2024)
Table 9. Global Lacosamide Oral Solution Revenue Market Share by Region (2024-2029)
Table 10. Global Lacosamide Oral Solution Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Lacosamide Oral Solution Sales by Region (2018-2024) & (K Bottles)
Table 12. Global Lacosamide Oral Solution Sales by Region (2024-2029) & (K Bottles)
Table 13. Global Lacosamide Oral Solution Sales Market Share by Region (2018-2024)
Table 14. Global Lacosamide Oral Solution Sales Market Share by Region (2024-2029)
Table 15. Global Lacosamide Oral Solution Sales by Manufacturers (2018-2024) & (K Bottles)
Table 16. Global Lacosamide Oral Solution Sales Share by Manufacturers (2018-2024)
Table 17. Global Lacosamide Oral Solution Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Lacosamide Oral Solution Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Lacosamide Oral Solution, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Lacosamide Oral Solution Price by Manufacturers 2018-2024 (US$/Bottle)
Table 21. Global Lacosamide Oral Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Lacosamide Oral Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Oral Solution as of 2022)
Table 23. Global Key Manufacturers of Lacosamide Oral Solution, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Lacosamide Oral Solution, Product Offered and Application
Table 25. Global Key Manufacturers of Lacosamide Oral Solution, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Lacosamide Oral Solution Sales by Type (2018-2024) & (K Bottles)
Table 28. Global Lacosamide Oral Solution Sales by Type (2024-2029) & (K Bottles)
Table 29. Global Lacosamide Oral Solution Sales Share by Type (2018-2024)
Table 30. Global Lacosamide Oral Solution Sales Share by Type (2024-2029)
Table 31. Global Lacosamide Oral Solution Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Lacosamide Oral Solution Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Lacosamide Oral Solution Revenue Share by Type (2018-2024)
Table 34. Global Lacosamide Oral Solution Revenue Share by Type (2024-2029)
Table 35. Lacosamide Oral Solution Price by Type (2018-2024) & (US$/Bottle)
Table 36. Global Lacosamide Oral Solution Price Forecast by Type (2024-2029) & (US$/Bottle)
Table 37. Global Lacosamide Oral Solution Sales by Application (2018-2024) & (K Bottles)
Table 38. Global Lacosamide Oral Solution Sales by Application (2024-2029) & (K Bottles)
Table 39. Global Lacosamide Oral Solution Sales Share by Application (2018-2024)
Table 40. Global Lacosamide Oral Solution Sales Share by Application (2024-2029)
Table 41. Global Lacosamide Oral Solution Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Lacosamide Oral Solution Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Lacosamide Oral Solution Revenue Share by Application (2018-2024)
Table 44. Global Lacosamide Oral Solution Revenue Share by Application (2024-2029)
Table 45. Lacosamide Oral Solution Price by Application (2018-2024) & (US$/Bottle)
Table 46. Global Lacosamide Oral Solution Price Forecast by Application (2024-2029) & (US$/Bottle)
Table 47. US & Canada Lacosamide Oral Solution Sales by Type (2018-2024) & (K Bottles)
Table 48. US & Canada Lacosamide Oral Solution Sales by Type (2024-2029) & (K Bottles)
Table 49. US & Canada Lacosamide Oral Solution Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Lacosamide Oral Solution Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Lacosamide Oral Solution Sales by Application (2018-2024) & (K Bottles)
Table 52. US & Canada Lacosamide Oral Solution Sales by Application (2024-2029) & (K Bottles)
Table 53. US & Canada Lacosamide Oral Solution Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Lacosamide Oral Solution Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Lacosamide Oral Solution Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Lacosamide Oral Solution Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Lacosamide Oral Solution Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Lacosamide Oral Solution Sales by Country (2018-2024) & (K Bottles)
Table 59. US & Canada Lacosamide Oral Solution Sales by Country (2024-2029) & (K Bottles)
Table 60. Europe Lacosamide Oral Solution Sales by Type (2018-2024) & (K Bottles)
Table 61. Europe Lacosamide Oral Solution Sales by Type (2024-2029) & (K Bottles)
Table 62. Europe Lacosamide Oral Solution Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Lacosamide Oral Solution Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Lacosamide Oral Solution Sales by Application (2018-2024) & (K Bottles)
Table 65. Europe Lacosamide Oral Solution Sales by Application (2024-2029) & (K Bottles)
Table 66. Europe Lacosamide Oral Solution Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Lacosamide Oral Solution Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Lacosamide Oral Solution Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Lacosamide Oral Solution Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Lacosamide Oral Solution Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Lacosamide Oral Solution Sales by Country (2018-2024) & (K Bottles)
Table 72. Europe Lacosamide Oral Solution Sales by Country (2024-2029) & (K Bottles)
Table 73. China Lacosamide Oral Solution Sales by Type (2018-2024) & (K Bottles)
Table 74. China Lacosamide Oral Solution Sales by Type (2024-2029) & (K Bottles)
Table 75. China Lacosamide Oral Solution Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Lacosamide Oral Solution Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Lacosamide Oral Solution Sales by Application (2018-2024) & (K Bottles)
Table 78. China Lacosamide Oral Solution Sales by Application (2024-2029) & (K Bottles)
Table 79. China Lacosamide Oral Solution Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Lacosamide Oral Solution Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Lacosamide Oral Solution Sales by Type (2018-2024) & (K Bottles)
Table 82. Asia Lacosamide Oral Solution Sales by Type (2024-2029) & (K Bottles)
Table 83. Asia Lacosamide Oral Solution Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Lacosamide Oral Solution Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Lacosamide Oral Solution Sales by Application (2018-2024) & (K Bottles)
Table 86. Asia Lacosamide Oral Solution Sales by Application (2024-2029) & (K Bottles)
Table 87. Asia Lacosamide Oral Solution Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Lacosamide Oral Solution Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Lacosamide Oral Solution Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Lacosamide Oral Solution Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Lacosamide Oral Solution Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Lacosamide Oral Solution Sales by Region (2018-2024) & (K Bottles)
Table 93. Asia Lacosamide Oral Solution Sales by Region (2024-2029) & (K Bottles)
Table 94. Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Type (2018-2024) & (K Bottles)
Table 95. Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Type (2024-2029) & (K Bottles)
Table 96. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Application (2018-2024) & (K Bottles)
Table 99. Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Application (2024-2029) & (K Bottles)
Table 100. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Country (2018-2024) & (K Bottles)
Table 106. Middle East, Africa and Latin America Lacosamide Oral Solution Sales by Country (2024-2029) & (K Bottles)
Table 107. Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
Table 108. Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Major Businesses
Table 109. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 110. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments
Table 112. China Resources Double-crane Pharmaceutical Co., Ltd. Company Information
Table 113. China Resources Double-crane Pharmaceutical Co., Ltd. Description and Major Businesses
Table 114. China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 115. China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. China Resources Double-crane Pharmaceutical Co., Ltd. Recent Developments
Table 117. Haida Shehuage Pharmaceutical Co., Ltd. Company Information
Table 118. Haida Shehuage Pharmaceutical Co., Ltd. Description and Major Businesses
Table 119. Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 120. Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Haida Shehuage Pharmaceutical Co., Ltd. Recent Developments
Table 122. Shanghai Aucta Pharmaceuticals Co., Ltd. Company Information
Table 123. Shanghai Aucta Pharmaceuticals Co., Ltd. Description and Major Businesses
Table 124. Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 125. Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Shanghai Aucta Pharmaceuticals Co., Ltd. Recent Developments
Table 127. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 128. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Major Businesses
Table 129. Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 130. Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments
Table 132. Shandong Loncom Pharmaceutical Co., Ltd Company Information
Table 133. Shandong Loncom Pharmaceutical Co., Ltd Description and Major Businesses
Table 134. Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 135. Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Shandong Loncom Pharmaceutical Co., Ltd Recent Developments
Table 137. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
Table 138. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Major Businesses
Table 139. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 140. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments
Table 142. UCB Pharma Limited Company Information
Table 143. UCB Pharma Limited Description and Major Businesses
Table 144. UCB Pharma Limited Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 145. UCB Pharma Limited Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. UCB Pharma Limited Recent Developments
Table 147. Glenmark Pharma INC Company Information
Table 148. Glenmark Pharma INC Description and Major Businesses
Table 149. Glenmark Pharma INC Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 150. Glenmark Pharma INC Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Glenmark Pharma INC Recent Developments
Table 152. Vista Pharm INC Company Information
Table 153. Vista Pharm INC Description and Major Businesses
Table 154. Vista Pharm INC Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 155. Vista Pharm INC Lacosamide Oral Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Vista Pharm INC Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Lacosamide Oral Solution Distributors List
Table 160. Lacosamide Oral Solution Customers List
Table 161. Lacosamide Oral Solution Market Trends
Table 162. Lacosamide Oral Solution Market Drivers
Table 163. Lacosamide Oral Solution Market Challenges
Table 164. Lacosamide Oral Solution Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Lacosamide Oral Solution Product Picture
Figure 2. Global Lacosamide Oral Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Lacosamide Oral Solution Market Share by Type in 2022 & 2029
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Lacosamide Oral Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Lacosamide Oral Solution Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Retail Drug Store
Figure 10. Online Sales
Figure 11. Others
Figure 12. Lacosamide Oral Solution Report Years Considered
Figure 13. Global Lacosamide Oral Solution Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Lacosamide Oral Solution Revenue 2018-2029 (US$ Million)
Figure 15. Global Lacosamide Oral Solution Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Lacosamide Oral Solution Revenue Market Share by Region (2018-2029)
Figure 17. Global Lacosamide Oral Solution Sales 2018-2029 ((K Bottles)
Figure 18. Global Lacosamide Oral Solution Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Lacosamide Oral Solution Sales YoY (2018-2029) & (K Bottles)
Figure 20. US & Canada Lacosamide Oral Solution Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Lacosamide Oral Solution Sales YoY (2018-2029) & (K Bottles)
Figure 22. Europe Lacosamide Oral Solution Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Lacosamide Oral Solution Sales YoY (2018-2029) & (K Bottles)
Figure 24. China Lacosamide Oral Solution Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Lacosamide Oral Solution Sales YoY (2018-2029) & (K Bottles)
Figure 26. Asia (excluding China) Lacosamide Oral Solution Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Lacosamide Oral Solution Sales YoY (2018-2029) & (K Bottles)
Figure 28. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Lacosamide Oral Solution Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Lacosamide Oral Solution in the World: Market Share by Lacosamide Oral Solution Revenue in 2022
Figure 31. Global Lacosamide Oral Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
Figure 33. Global Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
Figure 34. Global Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
Figure 35. Global Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Lacosamide Oral Solution Revenue Share by Country (2018-2029)
Figure 41. US & Canada Lacosamide Oral Solution Sales Share by Country (2018-2029)
Figure 42. U.S. Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
Figure 45. Europe Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
Figure 46. Europe Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
Figure 47. Europe Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
Figure 48. Europe Lacosamide Oral Solution Revenue Share by Country (2018-2029)
Figure 49. Europe Lacosamide Oral Solution Sales Share by Country (2018-2029)
Figure 50. Germany Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 51. France Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 55. China Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
Figure 56. China Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
Figure 57. China Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
Figure 58. China Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
Figure 59. Asia Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
Figure 60. Asia Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
Figure 61. Asia Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
Figure 62. Asia Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
Figure 63. Asia Lacosamide Oral Solution Revenue Share by Region (2018-2029)
Figure 64. Asia Lacosamide Oral Solution Sales Share by Region (2018-2029)
Figure 65. Japan Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 69. India Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Lacosamide Oral Solution Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Lacosamide Oral Solution Sales Share by Country (2018-2029)
Figure 76. Brazil Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Lacosamide Oral Solution Revenue (2018-2029) & (US$ Million)
Figure 81. Lacosamide Oral Solution Value Chain
Figure 82. Lacosamide Oral Solution Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed